Valneva SE (VALN) Gross Margin Growth (1y) (2022 - 2026)

Valneva SE (VALN) Gross Margin Growth (1y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -93.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -91.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 236.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 228.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 6.06 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -475.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 1,034.00
10 Valneva SE 618.67 Mn 477.41 Mn 1.86 Mn -4,552.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -4,552.00
Mar 31, 2026 -3,791.00
Dec 31, 2025 -4,008.00
Sep 30, 2025 -4,787.00
Jun 30, 2025 1,176.00
Mar 31, 2025 2,085.00
Dec 31, 2024 860.00
Sep 30, 2024 -651.00
Jun 30, 2024 2,125.00
Mar 31, 2024 -654.00
Dec 31, 2023 4,705.00
Sep 30, 2023 -3,514.00
Jun 30, 2023 13,792.00
Mar 31, 2023 232.00
Dec 31, 2022 -9,908.00
Sep 30, 2022 53,861.00
Jun 30, 2022 -13,795.00
Mar 31, 2022 -34.00